Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
27.94
Dollar change
-1.01
Percentage change
-3.49
%
Index- P/E- EPS (ttm)-2.18 Insider Own17.70% Shs Outstand105.04M Perf Week-19.13%
Market Cap3.34B Forward P/E- EPS next Y-0.86 Insider Trans-0.27% Shs Float98.51M Perf Month-25.65%
Income-255.10M PEG- EPS next Q-0.50 Inst Own80.59% Short Float8.65% Perf Quarter-33.16%
Sales618.73M P/S5.41 EPS this Y27.06% Inst Trans-1.00% Short Ratio6.12 Perf Half Y-29.59%
Book/sh6.22 P/B4.49 EPS next Y45.69% ROA-25.59% Short Interest8.52M Perf Year-49.20%
Cash/sh3.25 P/C8.60 EPS next 5Y- ROE-32.98% 52W Range26.75 - 63.57 Perf YTD-50.07%
Dividend Est.- P/FCF- EPS past 5Y-13.04% ROI-30.93% 52W High-56.05% Beta1.94
Dividend TTM- Quick Ratio4.11 Sales past 5Y35.76% Gross Margin60.41% 52W Low4.45% ATR (14)1.76
Dividend Ex-Date- Current Ratio4.69 EPS Y/Y TTM-49.04% Oper. Margin-33.03% RSI (14)21.38 Volatility7.07% 4.28%
Employees1259 Debt/Eq0.13 Sales Y/Y TTM19.81% Profit Margin-41.23% Recom1.75 Target Price53.57
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-175.27% Payout- Rel Volume1.49 Prev Close28.95
Sales Surprise0.68% EPS Surprise-17.38% Sales Q/Q17.76% EarningsApr 30 AMC Avg Volume1.39M Price27.94
SMA20-20.69% SMA50-30.78% SMA200-38.76% Trades Volume2,078,457 Change-3.49%
Date Action Analyst Rating Change Price Target Change
Dec-14-23Initiated Guggenheim Buy $60
Dec-13-23Initiated Wolfe Research Outperform $55
Dec-12-23Upgrade BofA Securities Underperform → Neutral $36 → $54
Jul-05-23Resumed JP Morgan Overweight $65
May-10-23Initiated Barclays Overweight $65
Mar-31-23Initiated Stephens Overweight $65
Feb-02-23Initiated UBS Neutral $50
Dec-14-22Initiated Deutsche Bank Buy $50
Aug-18-22Downgrade Goldman Neutral → Sell $55 → $35
Jul-25-22Initiated Canaccord Genuity Buy $55
Apr-18-24 06:46AM
Apr-10-24 04:05PM
Mar-26-24 09:00AM
Mar-21-24 04:05PM
Mar-13-24 04:05PM
08:17AM Loading…
08:17AM
Mar-01-24 02:00PM
Feb-27-24 11:55AM
Feb-20-24 04:05PM
Feb-16-24 10:21AM
08:14AM
Feb-15-24 06:00PM
05:20PM
04:40PM
04:17PM
04:05PM Loading…
04:05PM
Feb-08-24 10:00AM
Feb-07-24 04:05PM
Feb-05-24 04:05PM
11:18AM
Jan-30-24 01:03PM
Jan-24-24 04:05PM
Jan-08-24 09:00AM
Dec-21-23 04:05PM
Dec-20-23 04:05PM
Dec-19-23 09:00AM
Dec-13-23 04:26PM
Dec-10-23 11:59AM
Dec-07-23 09:00AM
Nov-23-23 11:05AM
09:08AM Loading…
Nov-19-23 09:08AM
Nov-17-23 05:22PM
Nov-09-23 01:12AM
Nov-06-23 04:05PM
Nov-03-23 11:09AM
09:14AM
Nov-02-23 07:43PM
07:30PM
04:52PM
04:05PM
Nov-01-23 04:05PM
Oct-31-23 10:01AM
Oct-30-23 03:45PM
Oct-26-23 04:05PM
Oct-11-23 04:05PM
Oct-10-23 12:06PM
Sep-28-23 08:23AM
Sep-19-23 01:08PM
Sep-18-23 11:52AM
Sep-14-23 04:36PM
Sep-08-23 07:37PM
Sep-05-23 09:00AM
Aug-30-23 04:05PM
Aug-29-23 04:30PM
Aug-09-23 07:14AM
Aug-04-23 04:10PM
Aug-03-23 10:00PM
06:45PM
05:40PM
04:46PM
04:05PM
Jul-13-23 04:05PM
Jul-05-23 07:30PM
Jun-01-23 09:00AM
May-25-23 11:43AM
May-24-23 04:05PM
12:30PM
May-18-23 02:57PM
11:37AM
May-17-23 04:05PM
May-14-23 04:05PM
May-04-23 06:44AM
May-03-23 05:45PM
04:05PM
Apr-27-23 12:25PM
Apr-25-23 04:06PM
Apr-12-23 04:05PM
Apr-11-23 07:13AM
Mar-07-23 09:15AM
Mar-02-23 05:47AM
Feb-22-23 04:30PM
Feb-16-23 07:13PM
Feb-15-23 05:25PM
04:05PM
Feb-09-23 10:01AM
Feb-08-23 10:00AM
Feb-06-23 09:00AM
Feb-02-23 12:58PM
Jan-19-23 04:05PM
Jan-17-23 04:10AM
Jan-10-23 12:02PM
Dec-28-22 04:05PM
Dec-22-22 07:03AM
Dec-08-22 04:05PM
Dec-06-22 05:42PM
Dec-01-22 05:28AM
Nov-09-22 04:05PM
06:14AM
Nov-04-22 07:24PM
11:37AM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerMar 04 '24Sale44.004,660205,021842,900Mar 06 04:12 PM
Saxonov SergeChief Executive OfficerFeb 22 '24Sale46.342,821130,737847,560Feb 26 04:13 PM
Hindson Benjamin J.See RemarksFeb 22 '24Sale46.342,613121,098283,059Feb 26 04:12 PM
McAnear Justin J.Chief Financial OfficerFeb 22 '24Sale46.341,86586,43295,240Feb 26 04:12 PM
Saxonov SergeChief Executive OfficerFeb 15 '24Sale48.875,000244,332850,381Feb 20 04:20 PM
Saxonov SergeChief Executive OfficerFeb 09 '24Sale49.531,00049,530855,381Feb 13 04:56 PM
Saxonov SergeChief Executive OfficerJan 16 '24Sale45.244,000180,956856,381Jan 18 04:49 PM
Hindson Benjamin J.See RemarksDec 28 '23Option Exercise11.488,33495,674285,672Dec 29 04:19 PM
Saxonov SergeChief Executive OfficerDec 27 '23Option Exercise1.2014,93517,922860,381Dec 29 04:17 PM
Saxonov SergeChief Executive OfficerDec 14 '23Sale55.032,000110,065845,446Dec 18 05:43 PM
Saxonov SergeChief Executive OfficerNov 24 '23Sale43.723,723162,751847,446Nov 27 06:15 PM
Saxonov SergeChief Executive OfficerNov 22 '23Sale43.343,757162,816851,169Nov 27 06:15 PM
Wilbur JamesChief Commercial OfficerNov 22 '23Sale43.343,464150,11883,342Nov 27 06:18 PM
Hindson Benjamin J.See RemarksNov 22 '23Sale43.343,449149,468277,338Nov 27 06:16 PM
McAnear Justin J.Chief Financial OfficerNov 22 '23Sale43.341,67972,76297,105Nov 27 06:15 PM
Wilbur JamesChief Commercial OfficerNov 20 '23Sale42.0914,718619,49486,806Nov 22 04:30 PM
Saxonov SergeChief Executive OfficerNov 14 '23Sale39.522,00079,041854,926Nov 16 04:22 PM
Saxonov SergeChief Executive OfficerOct 17 '23Sale39.511,97978,187856,926Oct 18 04:33 PM
Saxonov SergeChief Executive OfficerOct 16 '23Sale39.5021830858,905Oct 18 04:33 PM
Saxonov SergeChief Executive OfficerSep 14 '23Sale49.372,00098,739862,093Sep 18 04:43 PM
Wilbur JamesChief Commercial OfficerAug 22 '23Sale45.789,699444,031101,253Aug 24 05:08 PM
Saxonov SergeChief Executive OfficerAug 22 '23Sale45.783,757172,000864,093Aug 24 05:11 PM
Hindson Benjamin J.See RemarksAug 22 '23Sale45.783,449157,899280,787Aug 24 05:08 PM
McAnear Justin J.Chief Financial OfficerAug 22 '23Sale45.781,67876,82198,784Aug 24 05:09 PM
Saxonov SergeChief Executive OfficerAug 14 '23Sale50.112,000100,212867,850Aug 16 05:11 PM
Hindson Benjamin J.See RemarksAug 01 '23Option Exercise11.486,97080,016291,206Aug 03 04:23 PM
Hindson Benjamin J.See RemarksAug 01 '23Sale62.216,970433,612284,236Aug 03 04:23 PM
Saxonov SergeChief Executive OfficerJul 19 '23Option Exercise5.0420,845105,059909,850Jul 21 05:32 PM
Hindson Benjamin J.See RemarksJul 19 '23Option Exercise5.4913,94076,492298,176Jul 21 05:31 PM
Saxonov SergeChief Executive OfficerJul 19 '23Sale60.0340,0002,401,088869,850Jul 21 05:32 PM
Hindson Benjamin J.See RemarksJul 19 '23Sale60.0313,940836,834284,236Jul 21 05:31 PM
Saxonov SergeChief Executive OfficerJul 14 '23Sale58.052,000116,090889,005Jul 18 06:26 PM
Saxonov SergeChief Executive OfficerJun 14 '23Sale58.162,000116,328891,005Jun 16 05:37 PM
STUELPNAGEL JOHN RDirectorJun 05 '23Sale54.8910,000548,894333,736Jun 07 06:32 PM
Saxonov SergeChief Executive OfficerMay 23 '23Sale55.062,602143,271893,190May 23 07:51 PM
Hindson Benjamin J.See RemarksMay 23 '23Sale55.062,388131,487284,236May 25 05:49 PM
McAnear Justin J.Chief Financial OfficerMay 23 '23Sale55.061,66591,682100,462May 25 05:48 PM
Wilbur JamesChief Commercial OfficerMay 23 '23Sale55.0731617,401110,952May 25 05:49 PM
Saxonov SergeChief Executive OfficerMay 15 '23Sale53.352,000106,702895,792May 17 04:35 PM
Mammen MathaiDirectorMay 11 '23Option Exercise1.16200,000232,000202,745May 15 04:37 PM
Mammen MathaiDirectorMay 11 '23Sale52.8233,0001,743,086169,745May 15 04:37 PM